News & Events about Castle Biosciences Inc.
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the publication of a study in JCO Precision Oncology1 in which...
NEW YORK, June 25, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Comerica Incorporated (NYSE: CMA), Advance Auto Parts, Inc. (NYSE: AAP), EPAM Systems, Inc. (NYSE: EPAM), and Castle Biosciences, ...
NEW YORK, June 19, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Texas Capital Bancshares, Inc. (NASDAQ: TCBI), EPAM Systems, Inc. (NYSE: EPAM), and Castle Biosciences, Inc. (NASDAQ: CSTL). Our ...
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Castle Biosciences, Inc. (Castle or the Company) (NASDAQ: CSTL) on behalf of Castle stockholders. Our investigation concerns whether Castle has violated the federal...
NEW YORK, June 13, 2023 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Castle Biosciences, Inc. (Castle or the Company) (NASDAQ: CSTL). The investigation concerns whether Castle and/or certain of its officers have violated the federal securities ...